Programmable infusion pump and catheter: Evaluation using 3-Tesla magnetic resonance imaging

Neuromodulation

Volumn 11, Issue 3, 2008, Pages 163-170

  Shellock, Frank G ^a,d   Crivelli, Rocco ^b   Venugopalan, Ramakrishna ^c,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b JOHNSON AND JOHNSON   (United States)

^c Research and Development Department of Codman and Shurtleff Inc   (United States)

^d Education   (United States)

Author keywords

Artifacts; Catheter; Heating; Implants; Magnetic resonance imaging (MRI); MRI safety; Pump

Indexed keywords

SILICONE;

ARTICLE; ARTIFACT; CATHETER; CATHETER ABLATION; CATHETERIZATION; HEATING; INFUSION PUMP; MAGNETIC FIELD; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; TORQUE;

EID: 47349131454     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2008.00162.x     Document Type: Article

References (26)

1. Anderson V, Burchiel K. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999 44:289 301.
2. Kamran S, Wright B. Complications of intrathecal drug delivery systems. Neuromodulation 2001 4:111 115.
3. Follett K, Burchiel K, Deer T et al. Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation 2003 6:32 41.
4. Simpson R. Mechanisms of action of intrathecal medications. Neurosurg Clin N Am 2003 14:353 364.
5. Turner M. Intrathecal drug delivery. Acta Neurchir Suppl 2003 87:29 35.
6. Smith T, Swainey C, Coyne P. Pain management, including intrathecal pumps. Curr Pain Headache Rep 2005 9:243 248.
7. von Roemeling R, Lanning RM, Eames FA. MR imaging of patients with implanted drug infusion pumps. J Magn Reson Imaging 1991 1:77 81.
8. Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004 232:635 652.
9. Shellock FG. Reference manual for magnetic resonance safety, implants and devices: 2008 edition. Los Angeles, CA:Biomedical Research Publishing Group, 2008.
10. Buchler P, Simon A, Burger J et al. Safety of active implantable devices during MRI examinations: a finite element analysis of an implantable pump. IEEE Trans Biomed Eng 2007 54:726 733.
11. Baker K, Nyenhuis JA, Hrdlicka G, Rezai AR, Tkach JA, Shellock FG. Neurostimulator implants: assessment of magnetic field interactions associated with 1.5- and 3.0-tesla MR systems. J Magn Reson Imaging 2005 21:72 77.
12. Shellock FG, Habibi R, Knebel J. Programmable CSF shunt valve: in vitro assessment of MRI safety at 3-Tesla. Am J Neuroradiol 2006 27:661 665.
13. Shellock FG, Wilson SF, Mauge CP. Magnetically programmable shunt valve: MRI at 3-Tesla. Magn Reson Imaging 2007 25:1116 1121.
14. Shellock FG, Begnaud J, Inman DM. VNS Therapy System: in vitro evaluation of MRI-related heating and function at 1.5- and 3-Tesla. Neuromodulation 2006 9:204 213.
15. Shellock FG, Cosendai G, Park S-M, Nyenhuis JA. Implantable microstimulator: magnetic resonance safety at 1.5-tesla. Invest Radiol 2004 39:591 599.
16. Shellock FG, Fischer L, Fieno DS. Cardiac pacemakers and implantable cardioverter defibrillators: in vitro evaluation of MRI safety at 1.5-tesla. J Cardiovasc Magn Reson 2007 9:31 31.
17. American Society for Testing Materials (ASTM) International: F2052. Standard test method for measurement of magnetically induced displacement force on passive implants in the magnetic resonance environment. In:Annual Book of ASTM Standards, Volume 13.01, Medical Devices West Conshohocken, PA, 2001:1576 1580.
18. American Society for Testing Materials (ASTM) International: F2213-04. Standard test method for measurement of magnetically induced torque on passive implants in the magnetic resonance environment. West Conshohocken, PA:American Society for Testing and Materials (ASTM) International, 2004.
19. American Society for Testing Materials (ASTM) International: F2182-02. Test method for measurement of radio frequency induced heating near passive implants during magnetic resonance imaging. West Conshohocken, PA:American Society for Testing and Materials (ASTM) International, 2003.
20. http://www.fda.gov/cdrh/maude.html.
21. Shellock FG. Radiofrequency energy-induced heating during MR procedures: a review. J Magn Reson Imaging 2000 12:30 36.
22. International Standards Organization (ISO) 14708-1. Implants for surgery - Active implantable medical devices - Part 1: general requirements for safety, marking and for information to be provided by the manufacturer, 2000.
23. Olsrud J, Latt J, Brockstedt S, Romner B, Bjorkman-Burtscher IM. Magnetic resonance imaging artifacts caused by aneurysm clips and shunt valves: dependence on field strength (1.5 and 3 tesla) and imaging parameters. J Magn Reson Imaging 2005 22:433 437.
24. Graf H, Lauer UA, Berger A, Schick F. RF artifacts caused by metallic implants or instruments which get more prominent at 3-Tesla: an in vitro study. Magn Reson Imaging 2005 23:493 499.
25. Shellock FG, Crues JV. Commentary: MR safety and the American College of Radiology White Paper. Am J Roentgenol 2002 178:1349 1352.
26. American Society for Testing Materials (ASTM) International, Designation: F2503-05. Standard practice for marking medical devices and other items for safety in the magnetic resonance environment. West Conshohocken, PA:ASTM International, 2005.